RKDA
Arcadia Biosciences, Inc.Company with tickers: RKDA
CIK
1469443
CUSIP
039014303
Shares Outstanding
2,056,884
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $1,100,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | $-779,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-4,385,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-2.11 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $-2.11 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |